CRISPR Medicine News, 6 August 2020 | CRISPR corrects FOXP3 in rare childhood disease - CRISPR Medicine

CRISPR corrects rare childhood disease

Rosa Bacchetta and colleagues from Stanford University have demonstrated a smart CRISPR gene editing strategy as a feasible therapy for a rare, life-threatening paediatric autoimmune disease. Read more about the approach to treat IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome by inserting the FOXP3 gene at exactly the right spot in the genome in our interview with Bacchetta.

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.